AcuCort AB (ACUC.ST)
ACUC.ST Stock Price Chart
Explore AcuCort AB interactive price chart. Choose custom timeframes to analyze ACUC.ST price movements and trends.
ACUC.ST Company Profile
Discover essential business fundamentals and corporate details for AcuCort AB (ACUC.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
24 Apr 2017
Employees
4.00
Website
https://www.acucort.comCEO
Jonas Jonmark
Description
AcuCort AB (publ) develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions. It offers Zeqmelit, a medicine used for the treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting, as well as for the treatment of COVID-19 patients who need supplemental oxygen treatment. AcuCort AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
ACUC.ST Financial Timeline
Browse a chronological timeline of AcuCort AB corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 9 Oct 2023
Shares were split 251 : 200 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 20 Oct 2021
Shares were split 211 : 200 , changing the number of shares outstanding and the price per share accordingly.
ACUC.ST Stock Performance
Access detailed ACUC.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.